12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
- Bone Biologics (NASDAQ:BBLG) stock moved upwards by 56.0% to $0.81 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 2.3 million shares, which is 878.8 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $2.5 million. The company's, Q3 earnings came out yesterday.
- Exagen (NASDAQ:XGN) stock rose 15.78% to $1.76. The market value of their outstanding shares is at $29.6 million. As per the press release, Q3 earnings came out 2 days ago.
- PAVmed (NASDAQ:PAVM) shares increased by 11.31% to $0.25. The company's market cap stands at $27.4 million. As per the news, the Q3 earnings report came out yesterday.
- GRI Bio (NASDAQ:GRI) shares rose 9.9% to $1.22. The market value of their outstanding shares is at $3.6 million.
- Surrozen (NASDAQ:SRZN) shares rose 6.2% to $0.4. The company's market cap stands at $12.3 million.
- Heart Test Laboratories (NASDAQ:HSCS) shares increased by 6.0% to $0.16. Trading volume for this security closed at 31.8 million, accounting for 1722.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.7 million.
Losers
- Augmedix (NASDAQ:AUGX) shares decreased by 20.8% to $4.3 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 66.5K shares, which is 29.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $175.4 million.
- Impel Pharmaceuticals (NASDAQ:IMPL) shares declined by 15.94% to $0.24. The market value of their outstanding shares is at $5.5 million.
- OpGen (NASDAQ:OPGN) stock declined by 9.34% to $0.44. The company's market cap stands at $4.7 million. As per the press release, Q3 earnings came out yesterday.
- Autolus Therapeutics (NASDAQ:AUTL) shares declined by 9.2% to $3.85. The market value of their outstanding shares is at $669.8 million.
- Baudax Bio (NASDAQ:BXRX) stock decreased by 8.66% to $0.17. The market value of their outstanding shares is at $1.5 million.
- Cocrystal Pharma (NASDAQ:COCP) shares fell 8.29% to $1.66. The company's market cap stands at $16.8 million. As per the news, the Q3 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.